Advertisement

Pulmonary Rehabilitation

  • Francesca de Blasio
  • Francesco de Blasio
  • Enrico CliniEmail author
Chapter

Abstract

Disability in chronic respiratory diseases (CRD) represents the impact of the disease on the patient’s life. Chronic airway diseases, included but not limited to COPD, are leading this burden.

Overall, the mobility-related dyspnea and the resulting decrease in exercise capacity substantially contribute to increased risk of disability, even after taking lung function impairment into account. Therefore, non-pharmacological interventions such as pulmonary rehabilitation (PR) might be particularly beneficial for these symptomatic patients to limit and to counteract the progressive loss of physical function and related problems.

In this chapter we will discuss the most recent evidence related to the assessment of individual’s disability in this population, and we will describe the variety of methods used in the clinical process of care called PR.

To date, PR results in substantial effectiveness when applied at the very early onset of disability in individuals suffering from CRD. Programme composition and strategies aimed at behavioural changes in the long-term appear the keys for success in the clinical practice.

Keywords

Rehabilitation Exercise Chronic respiratory diseases COPD Dyspnea 

References

  1. 1.
    Harber P. Respiratory disability: what is it, how can we measure it, what causes it and is it important? Thorax. 2009;64(4):280–2.PubMedGoogle Scholar
  2. 2.
    Eisner MD, Iribarren C, Blanc PD, Yelin EH, Ackerson L, Byl N, et al. Development of disability in chronic obstructive pulmonary disease: beyond lung function. Thorax. 2011;66(2):108–14.PubMedGoogle Scholar
  3. 3.
    Barreiro E, Gea J. Respiratory and limb muscle dysfunction in COPD. COPD. 2015;12(4):413–26.PubMedGoogle Scholar
  4. 4.
    Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–62.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81–8.PubMedGoogle Scholar
  6. 6.
    Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012;40(5):1115–22.PubMedGoogle Scholar
  7. 7.
    Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(2):629–34.PubMedGoogle Scholar
  8. 8.
    Gosselink R, Troosters T, Decramer M. Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2000;20(6):353–60.PubMedGoogle Scholar
  9. 9.
    Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res. 2007;8(1):25.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003;58(9):752–6.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Osthoff AK, Taeymans J, Kool J, Marcar V, van Gestel AJ. Association between peripheral muscle strength and daily physical activity in patients with COPD: a systematic literature review and meta-analysis. J Cardiopulm Rehabil Prev. 2013;33(6):351–9.PubMedGoogle Scholar
  12. 12.
    Butcher SJ, Pikaluk BJ, Chura RL, Walkner MJ, Farthing JP, Marciniuk DD. Associations between isokinetic muscle strength, high-level functional performance, and physiological parameters in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2012;7:537–42.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Patel MS, Mohan D, Andersson YM, Baz M, Samantha Kon SC, Canavan JL, et al. Phenotypic characteristics associated with reduced short physical performance battery score in COPD. Chest. 2014;145(5):1016–24.PubMedGoogle Scholar
  14. 14.
    Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153(3):976–80.PubMedGoogle Scholar
  15. 15.
    Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62(2):115–20.PubMedGoogle Scholar
  16. 16.
    Nyberg A, Saey D, Maltais F. Why and how limb muscle mass and function should be measured in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12(9):1269–77.PubMedGoogle Scholar
  17. 17.
    Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;71(3):733–8.PubMedGoogle Scholar
  18. 18.
    Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–6.PubMedGoogle Scholar
  19. 19.
    Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10(12):2807–13.PubMedGoogle Scholar
  20. 20.
    Kobayashi A, Yoneda T, Yoshikawa M, Ikuno M, Takenaka H, Fukuoka A, et al. The relation of fat-free mass to maximum exercise performance in patients with chronic obstructive pulmonary disease. Lung. 2000;178(2):119–27.PubMedGoogle Scholar
  21. 21.
    Schols AM, Mostert R, Soeters PB, Wouters EF. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax. 1991;46(10):695–9.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(9):859–67.PubMedGoogle Scholar
  23. 23.
    Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(6):809–13.PubMedGoogle Scholar
  24. 24.
    de Blasio F, Santaniello MG, de Blasio F, Mazzarella G, Bianco A, Lionetti L, et al. Raw BIA variables are predictors of muscle strength in patients with chronic obstructive pulmonary disease. Eur J Clin Nutr. 2017;71(11):1336–40.PubMedGoogle Scholar
  25. 25.
    Maddocks M, Kon SS, Jones SE, Canavan JL, Nolan CM, Higginson IJ, et al. Bioelectrical impedance phase angle relates to function, disease severity and prognosis in stable chronic obstructive pulmonary disease. Clin Nutr. 2015;34(6):1245–50.PubMedGoogle Scholar
  26. 26.
    de Blasio F, Scalfi L, Alicante P, Miracco Berlingieri G, Bellofiore B, de Blasio F. Malnutrition and sarcopenia in chronic obstructive pulmonary disease according to the new ESPEN definition and EWGSOP criteria. Eur Respir J. 2017;50(Suppl 61):PA400.Google Scholar
  27. 27.
    de Blasio F, Scalfi L, Di Gregorio A, Miracco Berlingieri G, De Martino M, de Blasio F. Raw bioelectrical impedance variables are predictors of survival in chronic obstructive pulmonary disease. Eur Respir J. 2017;50(Suppl 61):PA1094.Google Scholar
  28. 28.
    St-Onge MP, Wang J, Shen W, Wang Z, Allison DB, Heshka S, et al. Dual-energy x-ray absorptiometry-measured lean soft tissue mass: differing relation to body cell mass across the adult life span. J Gerontol A Biol Sci Med Sci. 2004;59(8):796–800.PubMedGoogle Scholar
  29. 29.
    Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Sundh J, Janson C, Lisspers K, Ställberg B, Montgomery S. Dyspnoea, obstruction, smoking and exacerbation (DOSE) index and mortality in COPD. Eur Respir J. 2011;38(Suppl 55):542S.Google Scholar
  31. 31.
    Borg G. Ratings of perceived exertion and heart rates during short-term cycle exercise and their use in a new cycling strength test. Int J Sports Med. 1982;3(3):153–8.PubMedGoogle Scholar
  32. 32.
    Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969;62(10):989–93.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Goldstein RE. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: The History P, and Laboratory Examinations. 3rd ed. Boston: Butterworths; 1990. Chapter 8.Google Scholar
  34. 34.
    Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG, Gosselink R, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29(1):185–209.PubMedGoogle Scholar
  35. 35.
    Weisman IM, Zeballos RJ. An integrated approach to the interpretation of cardiopulmonary exercise testing. Clin Chest Med. 1994;15(2):421–45.PubMedGoogle Scholar
  36. 36.
    Sue DY, Wasserman K. Impact of integrative cardiopulmonary exercise testing on clinical decision making. Chest. 1991;99(4):981–92.PubMedGoogle Scholar
  37. 37.
    Ferguson B. ACSM’s guidelines for exercise testing and prescription 9th Ed. 2014. J Can Chiropr Assoc. 2014;58(3):328.PubMedCentralGoogle Scholar
  38. 38.
    ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.Google Scholar
  39. 39.
    Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81.PubMedGoogle Scholar
  40. 40.
    Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47(12):1019–24.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Revill S, Morgan M, Singh S, Williams J, Hardman A. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax. 1999;54(3):213–22.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Albarrati AM, Gale NS, Enright S, Munnery MM, Cockcroft JR, Shale DJ. A simple and rapid test of physical performance in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:1785–91.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Bohannon RW, Bubela DJ, Magasi SR, Wang YC, Gershon RC. Sit-to-stand test: performance and determinants across the age-span. Isokinet Exerc Sci. 2010;18(4):235–40.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.PubMedGoogle Scholar
  45. 45.
    Holland AE, Wadell K, Spruit MA. How to adapt the pulmonary rehabilitation programme to patients with chronic respiratory disease other than COPD. Eur Respir Rev. 2013;22:577–86.PubMedGoogle Scholar
  46. 46.
    Breyer MK, Breyer-Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF, et al. Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res. 2010;11:112.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Dolmage TE, Goldstein RS. Effects of one-legged exercise training of patients with COPD. Chest. 2008;133(2):370–6.PubMedGoogle Scholar
  48. 48.
    Andrianopoulos V, Klijn P, Franssen FM, Spruit MA. Exercise training in pulmonary rehabilitation. Clin Chest Med. 2014;35(2):313–22.PubMedGoogle Scholar
  49. 49.
    Normandin EA, McCusker C, Connors M, Vale F, Gerardi D, ZuWallack RL. An evaluation of two approaches to exercise conditioning in pulmonary rehabilitation. Chest. 2002;121(4):1085–91.PubMedGoogle Scholar
  50. 50.
    Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991;143(1):9–18.PubMedGoogle Scholar
  51. 51.
    Janaudis-Ferreira T, Hill K, Goldstein R, Wadell K, Brooks D. Arm exercise training in patients with chronic obstructive pulmonary disease: a systematic review. J Cardiopulm Rehabil Prev. 2009;29(5):277–83.PubMedGoogle Scholar
  52. 52.
    Vogiatzis I, Nanas S, Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J. 2002;20(1):12–9.PubMedGoogle Scholar
  53. 53.
    Varga J, Porszasz J, Boda K, Casaburi R, Somfay A. Supervised high intensity continuous and interval training vs. self-paced training in COPD. Respir Med. 2007;101(11):2297–304.PubMedGoogle Scholar
  54. 54.
    Kortianou EA, Nasis IG, Spetsioti ST, Daskalakis AM, Vogiatzis I. Effectiveness of interval exercise training in patients with COPD. Cardiopulm Phys Ther J. 2010;21(3):12–9.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Probst VS, Troosters T, Pitta F, Decramer M, Gosselink R. Cardiopulmonary stress during exercise training in patients with COPD. Eur Respir J. 2006;27(6):1110–8.PubMedGoogle Scholar
  56. 56.
    Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334–59.PubMedGoogle Scholar
  57. 57.
    Gloeckl R, Marinov B, Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev. 2013;22(128):178–86.PubMedGoogle Scholar
  58. 58.
    O'Shea SD, Taylor NF, Paratz J. Peripheral muscle strength training in COPD: a systematic review. Chest. 2004;126(3):903–14.PubMedGoogle Scholar
  59. 59.
    Ortega F, Toral J, Cejudo P, Villagomez R, Sanchez H, Castillo J, et al. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(5):669–74.PubMedGoogle Scholar
  60. 60.
    Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003;168(9):1034–42.PubMedGoogle Scholar
  61. 61.
    Hawkins P, Johnson LC, Nikoletou D, Hamnegard CH, Sherwood R, Polkey MI, et al. Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax. 2002;57(10):853–9.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Garrod R, Mikelsons C, Paul EA, Wedzicha JA. Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1335–41.PubMedGoogle Scholar
  63. 63.
    Wedzicha JA. Heliox in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173(8):825–6.PubMedGoogle Scholar
  64. 64.
    Mazzuca SA. Does patient education in chronic disease have therapeutic value? J Chronic Dis. 1982;35(7):521–9.PubMedGoogle Scholar
  65. 65.
    Velloso M, Jardim JR. Study of energy expenditure during activities of daily living using and not using body position recommended by energy conservation techniques in patients with COPD. Chest. 2006;130(1):126–32.PubMedGoogle Scholar
  66. 66.
    Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour modification in COPD. Patient Educ Couns. 2004;52(3):271–7.PubMedGoogle Scholar
  67. 67.
    van Manen JG, Bindels PJ, Dekker FW, IJzermans C, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57(5):412–6.PubMedPubMedCentralGoogle Scholar
  68. 68.
    de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2003;84(8):1154–7.PubMedGoogle Scholar
  69. 69.
    Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(13):1329–35.PubMedGoogle Scholar
  70. 70.
    Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12(2):113–7.PubMedGoogle Scholar
  71. 71.
    Harrison SL, Greening NJ, Williams JE, Morgan MD, Steiner MC, Singh SJ. Have we underestimated the efficacy of pulmonary rehabilitation in improving mood? Respir Med. 2012;106(6):838–44.PubMedGoogle Scholar
  72. 72.
    Haas F, Salazar-Schicchi J, Axen K. Desensitization to dyspnea in chronic obstructive pulmonary disease. In: Casaburi R, Petty TL, editors. Principles and practice of pulmonary rehabilitation. Philadelphia: W.B. Saunders; 1993. p. 241–51.Google Scholar
  73. 73.
    Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006;173(1):79–83.PubMedGoogle Scholar
  74. 74.
    Gupta B, Kant S, Mishra R, Verma S. Nutritional status of chronic obstructive pulmonary disease patients admitted in hospital with acute exacerbation. J Clin Med Res. 2010;2(2):68–74.PubMedPubMedCentralGoogle Scholar
  75. 75.
    Hallin R, Koivisto-Hursti UK, Lindberg E, Janson C. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2006;100(3):561–7.PubMedGoogle Scholar
  76. 76.
    Odencrants S, Ehnfors M, Ehrenberg A. Nutritional status and patient characteristics for hospitalised older patients with chronic obstructive pulmonary disease. J Clin Nurs. 2008;17(13):1771–8.PubMedGoogle Scholar
  77. 77.
    Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:Cd003793.Google Scholar
  78. 78.
    Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355(9201):362–8.PubMedGoogle Scholar
  79. 79.
    Spruit MA, Troosters T, Trappenburg JC, Decramer M, Gosselink R. Exercise training during rehabilitation of patients with COPD: a current perspective. Patient Educ Couns. 2004;52(3):243–8.PubMedGoogle Scholar
  80. 80.
    Carr SJ, Goldstein RS, Brooks D. Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest. 2007;132(1):127–34.PubMedGoogle Scholar
  81. 81.
    Steele BG, Belza B, Cain KC, Coppersmith J, Lakshminarayan S, Howard J, et al. A randomized clinical trial of an activity and exercise adherence intervention in chronic pulmonary disease. Arch Phys Med Rehabil. 2008;89(3):404–12.PubMedGoogle Scholar
  82. 82.
    Waterhouse JC, Walters SJ, Oluboyede Y, Lawson RA. A randomised 2 × 2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up. Health Technol Assess. 2010;14(6.):i–v, vii–xi):1–140.Google Scholar
  83. 83.
    Spruit MA, Singh SJ, Rochester CL, Greening NJ, Franssen FME, Pitta F, et al. Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Eur Respir J. 2018;51:1.Google Scholar
  84. 84.
    Vogiatzis I, Rochester CL, Spruit MA, Troosters T, Clini EM. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement. Eur Respir J. 2016;47(5):1336–41.PubMedGoogle Scholar
  85. 85.
    Robles PG, Mathur S, Janaudis-Fereira T, Dolmage TE, Goldstein RS, Brooks D. Measurement of peripheral muscle strength in individuals with chronic obstructive pulmonary disease: a systematic review. J Cardiopulm Rehabil Prev. 2011;31(1):11–24.PubMedGoogle Scholar
  86. 86.
    Bachasson D, Wuyam B, Pepin JL, Tamisier R, Levy P, Verges S. Quadriceps and respiratory muscle fatigue following high-intensity cycling in COPD patients. PLoS One. 2013;8(12):e83432.PubMedPubMedCentralGoogle Scholar
  87. 87.
    Evans RA, Kaplovitch E, Beauchamp MK, Dolmage TE, Goldstein RS, Gillies CL, et al. Is quadriceps endurance reduced in COPD? Chest. 2015;147(3):673–84.PubMedGoogle Scholar
  88. 88.
    Vieira L, Bottaro M, Celes R, Viegas CA, Silva C. Isokinetic muscle evaluation of quadriceps in patients with chronic obstructive pulmonary disease. Rev Port Pneumol. 2010;16(5):717–36.PubMedGoogle Scholar
  89. 89.
    Thompson WR, Gordon NF, Pescatello LS. ACSM’s guidelines for exercise testing and prescription. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2010.Google Scholar
  90. 90.
    Couillard A, Koechlin C, Cristol JP, Varray A, Prefaut C. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J. 2002;20(5):1123–9.PubMedGoogle Scholar
  91. 91.
    Couillard A, Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with COPD. Am J Respir Crit Care Med. 2003;167:1664–9.PubMedGoogle Scholar
  92. 92.
    Stark T, Walker B, Phillips JK, Fejer R, Beck R. Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review. PM R. 2011;3(5):472–9.PubMedGoogle Scholar
  93. 93.
    O'Shea SD, Taylor NF, Paratz JD. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry. ArchPhysMed Rehabil. 2007;88(1):32–6.Google Scholar
  94. 94.
    Hartmann A, Knols R, Murer K, De Bruin ED. Reproducibility of an isokinetic strength-testing protocol of the knee and ankle in older adults. Gerontology. 2009;55(3):259–68.PubMedGoogle Scholar
  95. 95.
    Dourado VZ. Relationship of upper-limb and thoracic muscle strength to 6-min walk distance in COPD patients. Chest. 2006;129(3):551–7.PubMedGoogle Scholar
  96. 96.
    Burns SP, Spanier DE. Break-technique handheld dynamometry: relation between angular velocity and strength measurements. ArchPhysMed Rehabil. 2005;86(7):1420–6.Google Scholar
  97. 97.
    Burns SP, Breuninger A, Kaplan C, Marin H. Hand-held dynamometry in persons with tetraplegia: comparison of make- versus break-testing techniques. Am J Phys Med Rehabil. 2005;84(1):22–9.PubMedGoogle Scholar
  98. 98.
    Bachasson D, Villiot-Danger E, Verges S, Hayot M, Perez T, Chambellan A, et al. Maximal isometric voluntary quadriceps strength assessment in COPD. Revue des Maladies Respiratoires. 2014;31(8):765–70.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Francesca de Blasio
    • 1
  • Francesco de Blasio
    • 2
    • 3
  • Enrico Clini
    • 4
    • 5
    Email author
  1. 1.Department of Medical ScienceUniversity of TurinTorinoItaly
  2. 2.Department of Medicine and Health SciencesUniversity of MoliseCampobassoItaly
  3. 3.Respiratory Medicine and Pulmonary Rehabilitation SectionClinic Center S.p.A. Private HospitalNaplesItaly
  4. 4.Department of Medical and Surgical SciencesUniversity of Modena Reggio EmiliaModenaItaly
  5. 5.Pneumology UnitUniversity Hospital of ModenaModenaItaly

Personalised recommendations